- Home
- VRDN vs ZD Comparison
VRDN vs ZD Comparison
Compare VRDN & ZD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRDN | ZD |
|---|---|---|
| Founded | 2006 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Advertising |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.7B |
| IPO Year | 2014 | 1999 |
Fundamental Metrics
Financial Performance| Metric | VRDN | ZD |
|---|---|---|
| Price | $16.25 | $44.68 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 14 | 7 |
| Target Price | $35.46 | ★ $39.71 |
| AVG Volume (30 Days) | ★ 3.2M | 529.0K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.59 |
| Revenue | $5,706,000.00 | ★ $1,364,028,000.00 |
| Revenue This Year | $13.73 | N/A |
| Revenue Next Year | $279.00 | $2.16 |
| P/E Ratio | ★ N/A | $76.98 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $13.18 | $22.45 |
| 52 Week High | $34.29 | $50.55 |
Technical Indicators
Market Signals| Indicator | VRDN | ZD |
|---|---|---|
| Relative Strength Index (RSI) | 45.59 | 53.06 |
| Support Level | $15.65 | $39.78 |
| Resistance Level | $18.05 | $45.26 |
| Average True Range (ATR) | 0.83 | 1.64 |
| MACD | 0.02 | 0.34 |
| Stochastic Oscillator | 23.73 | 66.08 |
Price Performance
Historical ComparisonAbout VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. The company is developing two anti-IGF-1R product candidates, veligrotug for intravenous (IV) administration and elegrobart (formerly VRDN-003) for subcutaneous (SC) administration, to treat patients with TED. Our most advance program, veligrotug, is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of TED.
About ZD Ziff Davis Inc.
Ziff Davis Inc is a digital media and internet company operating a portfolio of brands across technology, shopping, gaming and entertainment, health and wellness, connectivity, and cybersecurity. The company has five reportable segments. The Technology & Shopping segment generates revenue from advertising and commerce content. The Gaming & Entertainment segment provides content, subscriptions, and digital storefront services. The Health & Wellness segment offers digital tools and content for health management. The Connectivity segment provides data and analytics solutions for network performance. The Cybersecurity & Martech segment delivers cloud-based software for security and marketing. It generates the majority of its revenue from the Health & Wellness segment.